The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125218872 12521887 2 F 20160619 20160725 20160701 20160803 EXP JP-AMGEN-JPNCT2016086201 AMGEN 69.00 YR E M Y 77.00000 KG 20160803 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125218872 12521887 1 PS panitumumab PANITUMUMAB 1 Intravenous drip 480 MG, Q2WK 125147 480 MG SOLUTION FOR INJECTION QOW
125218872 12521887 2 SS panitumumab PANITUMUMAB 1 125147 SOLUTION FOR INJECTION
125218872 12521887 3 SS panitumumab PANITUMUMAB 1 125147 SOLUTION FOR INJECTION
125218872 12521887 4 SS 5-FU /00098801/ FLUOROURACIL 1 Intravenous bolus 750 MG, Q2WK 0 750 MG QOW
125218872 12521887 5 SS 5-FU /00098801/ FLUOROURACIL 1 Intravenous drip 4600 MG, Q2WEEKS 0 4600 MG QOW
125218872 12521887 6 SS 5-FU /00098801/ FLUOROURACIL 1 0
125218872 12521887 7 SS ELPLAT OXALIPLATIN 1 Intravenous drip 160 MG, Q2WEEKS 0 160 MG QOW
125218872 12521887 8 SS ELPLAT OXALIPLATIN 1 0
125218872 12521887 9 SS ELPLAT OXALIPLATIN 1 0
125218872 12521887 10 C CALCIUM LEVOFOLINATE LEVOLEUCOVORIN CALCIUM 1 Intravenous drip 375 MG, Q2WEEKS U 0 375 MG QOW
125218872 12521887 11 C CALCIUM LEVOFOLINATE LEVOLEUCOVORIN CALCIUM 1 U 0
125218872 12521887 12 C CALCIUM LEVOFOLINATE LEVOLEUCOVORIN CALCIUM 1 U 0
125218872 12521887 13 C DECADRON /00016002/ DEXAMETHASONE 1 Intravenous (not otherwise specified) 6.6 MG, Q2WEEKS U 0 6.6 MG QOW
125218872 12521887 14 C ALOXI PALONOSETRON HYDROCHLORIDE 1 Intravenous (not otherwise specified) 0.75 MG, Q2WEEKS U 0 .75 MG QOW
125218872 12521887 15 C ZANTAC RANITIDINE HYDROCHLORIDE 1 Intravenous (not otherwise specified) 50 MG, Q2WEEKS U 0 50 MG QOW
125218872 12521887 16 C POLARAMINE DEXCHLORPHENIRAMINE MALEATE 1 Intravenous (not otherwise specified) 5 MG, Q2WEEKS U 0 5 MG QOW
125218872 12521887 17 C MICARDIS TELMISARTAN 1 Oral 40 MG, QD U 0 40 MG QD
125218872 12521887 18 C NIFEDIPINE. NIFEDIPINE 1 Oral 20 MG, QD U 0 20 MG QD
125218872 12521887 19 C RABEPRAZOLE NA RABEPRAZOLE SODIUM 1 Oral 10 MG, QD U 0 10 MG QD
125218872 12521887 20 C RABEPRAZOLE NA RABEPRAZOLE SODIUM 1 Oral 10 MG, QD U 0 10 MG QD
125218872 12521887 21 C ZETIA EZETIMIBE 1 Oral 10 MG, QD U 0 10 MG QD
125218872 12521887 22 C FEBURIC FEBUXOSTAT 1 Oral 20 MG, QD U 0 20 MG QD
125218872 12521887 23 C CAMOSTAT MESILATE CAMOSTAT MESYLATE 1 Oral 100 MG, QD U 0 100 MG QD
125218872 12521887 24 C GLACTIV SITAGLIPTIN 1 Oral 50 MG, QD U 0 50 MG QD
125218872 12521887 25 C BAYASPIRIN ASPIRIN 1 Oral 100 MG, QD U 0 100 MG QD
125218872 12521887 26 C DECADRON DEXAMETHASONE 1 Oral 8 MG, UNK U 0 8 MG
125218872 12521887 27 C MINOCYCLINE HYDROCHLORIDE. MINOCYCLINE HYDROCHLORIDE 1 Oral 100 MG, QD U 0 100 MG QD
125218872 12521887 28 C HEPARINOID CHONDROITIN SULFATE (BOVINE) 1 Transdermal UNK U 0
125218872 12521887 29 C AZUNOL /00317302/ 2 Oropharingeal UNK, TID U 0 TID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125218872 12521887 1 Colon cancer
125218872 12521887 2 Metastases to liver
125218872 12521887 3 Metastases to lung
125218872 12521887 4 Colon cancer
125218872 12521887 5 Metastases to liver
125218872 12521887 6 Metastases to lung
125218872 12521887 7 Colon cancer
125218872 12521887 8 Metastases to liver
125218872 12521887 9 Metastases to lung
125218872 12521887 10 Colon cancer
125218872 12521887 11 Metastases to liver
125218872 12521887 12 Metastases to lung
125218872 12521887 13 Prophylaxis
125218872 12521887 14 Prophylaxis
125218872 12521887 15 Prophylaxis
125218872 12521887 16 Prophylaxis
125218872 12521887 26 Prophylaxis
125218872 12521887 27 Prophylaxis
125218872 12521887 28 Prophylaxis
125218872 12521887 29 Prophylaxis

Outcome of event

Event ID CASEID OUTC COD
125218872 12521887 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125218872 12521887 Decreased appetite

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125218872 12521887 1 20160322 0
125218872 12521887 4 20160322 0
125218872 12521887 5 20160322 0
125218872 12521887 7 20160322 0
125218872 12521887 10 20160322 0
125218872 12521887 13 20160322 0
125218872 12521887 14 20160322 0
125218872 12521887 15 20160322 0
125218872 12521887 16 20160322 0
125218872 12521887 26 20160323 0
125218872 12521887 27 20160323 0
125218872 12521887 28 20160322 0
125218872 12521887 29 20160419 0